ETC
BNR

Exchange Traded Concepts’s Burning Rock Biotech BNR Stock Holding History

Exchange Traded Concepts’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,077
Closed -$20.1K – 1248
2023
Q3 		$20.1K Hold
2,077
– – ﹤0.01% 1131
2023
Q2 		$45.3K Buy
+2,077
New +$55.1K ﹤0.01% 1072

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Exchange Traded Concepts's BNR Position: Q4 2023 in Review

Exchange Traded Concepts sold out of Burning Rock Biotech (BNR) in Q4 2023, closing a stake of 2,077 shares — an estimated $20.1K sold.

Exchange Traded Concepts first reported a position in BNR in Q2 2023 and held it in 2 quarters. The position peaked at $45.3K in Q2 2023. 19 funds tracked by Wall St. Rank hold BNR as of Q4 2023.

  • Exchange Traded Concepts reported no remaining Burning Rock Biotech position as of Q4 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 2,077 Burning Rock Biotech shares in Q4 2023, an estimated $20.1K.
  • Exchange Traded Concepts first reported a position in Burning Rock Biotech in Q2 2023 and held it in 2 quarters.
  • Exchange Traded Concepts's Burning Rock Biotech position peaked at $45.3K in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2023.

Based on Exchange Traded Concepts's 13F filing for Q4 2023, filed 5 Jan 2024.